# Bunge Global (BG)

Sector: Agribusiness and food ingredients

| Field | Value |
|---|---|
| Price | $90.87 |
| Market cap | $17B |
| Intrinsic value source | AI estimate |
| Data as of | 2026-11-20 |
| Next earnings | 2027-01-29 (estimate) |

Analysts: Bullish

Picks: Research only

Discount category: Close to intrinsic value

## In short

The market expects the strong processing margins of 2026 to fall back, and Viterra savings with profit from the new Destrehan line through 2027 can lift its value.

## Themes and gap

- Themes: Tariffs and trade (trade-tariffs), Regulation and courts (regulation-legal)
- Gap type: Slow (slow)
- Why: Normal earnings after the Viterra combination become clear only over several years of results with average processing margins.

## About

Bunge Global SA (BG) buys, processes and sells agricultural commodities. It crushes soybeans and softseeds such as canola and sunflower into meal and oil, refines vegetable oils, makes specialty fats and ingredients, mills wheat and corn, and trades grain around the world. Its segments are Soybean Processing and Refining, Softseed Processing and Refining, Tropical Oils and Specialty Ingredients, and Grain Merchandising and Milling. Bunge combined with Viterra in July 2025, which added a large grain origination and handling network. Net sales were $69,706 million in the first nine months of 2026. Bunge is incorporated in Switzerland, has its headquarters in Chesterfield, Missouri, and its shares trade on the New York Stock Exchange.

## Thesis

The market prices Bunge close to the AI estimate, because it expects the strong processing margins of 2026 to fall back. Biofuel mandates in North America, the conflict with Iran and the war in Ukraine raised demand and prices for vegetable oils in 2026, and Bunge raised its 2026 outlook for adjusted EPS from $7.50 to $8.00 to $9.25 to $9.75. Investors do not know how much of this profit is normal. The AI estimate uses a normalized EPS below the 2026 outlook. For the value to rise, three things must be true. Bunge must show savings from the Viterra combination in its results. The new oilseed processing line of Bunge Chevron Ag Renewables in Destrehan, Louisiana, which started production after Q3 2026, must add profit. The 2027 outlook must show that earnings stay above the 2025 level when margins are average. The full-year 2026 results, expected in early 2027 with the first 2027 outlook, are the next test. A rise in normalized EPS would take several years of results to prove.

## Checkpoints

- Jan 29, 2027 (estimate): Full-year 2026 results and 2027 outlook. Status: Pending. Watch: 2026 adjusted EPS is within $9.25 to $9.75 and the first 2027 outlook is above the 2025 level of $7.57, and this passes; a 2027 outlook at or below $7.57 fails.
- 2027 (estimate): Viterra savings and Destrehan in the results. Status: Pending. Watch: Bunge reports savings from the Viterra combination and profit from the new Destrehan processing line through 2027, and this passes; no clear savings fail.

## Valuation

The intrinsic value for Bunge Global is an AI estimate from November 14, 2026. It is not an analyst's value. An AI research agent calculated it from the filings of Bunge with the SEC. The method is a multiple of normalized adjusted earnings per share. Normalized earnings are the earnings of an average year for processing and merchandising margins, not of a strong or a weak year. Adjusted earnings are after interest, so the estimate makes no debt adjustment. The Q3 2026 release of October 29, 2026 keeps the 2026 outlook for adjusted EPS at $9.25 to $9.75. The first 2026 outlook in the Q4 2025 release of February 4, 2026 was $7.50 to $8.00, and Bunge raised it in April and July 2026. The Q4 2025 release gives adjusted EPS of $7.57 for 2025 and $9.19 for 2024. Adjusted EPS was $6.38 in the first nine months of 2026. The Q3 2026 10-Q gives 192,143,784 registered shares outstanding at October 27, 2026 and 194,049,036 diluted weighted shares for Q3 2026. It gives total debt of $16,746 million and cash of $524 million at September 30, 2026, against readily marketable inventories of $14,696 million that Bunge can sell for cash quickly. Bunge expects net interest expense of $640 to $670 million in 2026. The normalized EPS and the multiples are assumptions. The low case assumes $7.50, the low end of the first 2026 outlook, at 10 times. It gives $75.00 per share. The base case assumes $9.00, a little below the 2026 outlook, because biofuel demand and trade disruption made 2026 margins strong, at 11.5 times. It gives $103.50 per share. The high case assumes $11.00, with savings from the Viterra combination and the new Destrehan processing line, at 12.5 times. It gives $137.50 per share. The estimate assumes weights of 25%, 50% and 25%. The weighted intrinsic value is $104.88 per share. Processing margins change with crops, trade policy and biofuel rules, so normalized EPS is hard to predict. Efficient scale and cost advantage are the possible sources of a lasting edge. Bunge has a large global network of processing plants, ports and grain elevators, and the Viterra combination of July 2025 made it larger. But its margins depend on markets that Bunge does not control, and other large merchants have similar networks. Switching costs and network effects are weak, because customers buy commodities on price.

As of 2026-11-14.

Sources:

- https://www.sec.gov/Archives/edgar/data/1996862/000162828026068051/epr09302026.htm
- https://www.sec.gov/Archives/edgar/data/1996862/000162828026068130/bg-20260930.htm
- https://www.sec.gov/Archives/edgar/data/1996862/000162828026005261/epr123120254.htm
- https://www.sec.gov/Archives/edgar/data/1996862/000162828026050334/epr06302026.htm
- https://www.sec.gov/Archives/edgar/data/1996862/000162828026028079/epr03312026.htm

## Balance sheet

- Cash: $524M
- Debt: $16.7B
- Net debt: $16.2B
- Undrawn credit line: $8.5B
- Debt due within 12 months: $7.8B
- Ratings: S&P A- (stable outlook), Moody's Baa1 (stable outlook), Fitch BBB+ (stable outlook)

At September 30, 2026, Bunge had cash and cash equivalents of $524 million. Total debt was $16,746 million: short-term debt of $6,471 million and long-term debt of $10,275 million, of which $1,331 million is due within a year. Debt rose from $14,051 million at December 31, 2025, mainly to fund inventories after the South American harvest. Readily marketable inventories, which Bunge can sell for cash quickly, were $14,696 million. Bunge had $8,515 million of unused committed credit facilities. Its long-term debt ratings were A- from S&P, Baa1 from Moody's and BBB+ from Fitch, all with a stable outlook. In 2026, Bunge issued $1,800 million of senior notes due from 2031 to 2036.

As of 2026-09-30.

Sources:

- https://www.sec.gov/Archives/edgar/data/1996862/000162828026068130/bg-20260930.htm
- https://www.sec.gov/Archives/edgar/data/1996862/000110465926098782/tm2623458d1_8k.htm
- https://www.sec.gov/Archives/edgar/data/1996862/000110465926032113/tm268104d3_8k.htm

## Dividends

- Dividend yield: 3.1% (last 12 months, at the current price)
- Paid per share, last 12 months: $2.84 (4 payments)
- Current annual rate: $2.88 ($0.72 x 4 a year)
- Payout ratio: 57% of the earnings of the last fiscal year (the year ended 2025-12-31)
- Latest ex-dividend date: 2026-08-18, $0.72 per share
- Growth from 2020 to 2025: 6.8% a year
- Growth from 2016 to 2025: 6.3% a year

Dividends per share by year: 2016: $1.60, 2017: $1.76, 2018: $1.92, 2019: $2.00, 2020: $2.00, 2021: $2.05, 2022: $2.30, 2023: $2.576, 2024: $2.703, 2025: $2.78.

Source: company filings and market data, read on 2026-11-13.

## Recent events

- 2026-10-29: Bunge reported Q3 2026 adjusted EPS of $2.56, up from $2.27, and kept its 2026 outlook for adjusted EPS of $9.25 to $9.75. It said that the new oilseed processing line of Bunge Chevron Ag Renewables in Destrehan, Louisiana, started production after the quarter.
- 2026-09-17: Bunge extended three revolving credit facilities: $1.1 billion to October 2027, $4.2 billion to October 2031 and $3.5 billion to October 2029.
- 2026-08-31: Bunge agreed to sell its two sugarcane mills in Brazil to COFCO International for about $383 million. It recorded an impairment loss of $66 million.
- 2026-08-19: Bunge issued $600 million of 5.000% senior notes due 2031.
- 2026-07-29: Bunge reported Q2 2026 results and raised its 2026 outlook for adjusted EPS to $9.25 to $9.75, from $9.00 to $9.50.
- 2026-05-20: Shareholders approved a dividend of $2.88 per share, paid in four quarterly payments of $0.72, up 3% from $0.70.
- 2026-04-29: Bunge reported Q1 2026 adjusted EPS of $1.83 and raised its 2026 outlook for adjusted EPS to $9.00 to $9.50, from $7.50 to $8.00.
- 2026-03-09: The board approved a new share repurchase program of up to $3.0 billion, with no end date. Bunge bought back no shares in Q3 2026.
- 2026-02-04: Bunge reported 2025 adjusted EPS of $7.57, down from $9.19 in 2024, and gave a first 2026 outlook for adjusted EPS of $7.50 to $8.00.

## Latest news and filings

- Last earnings: 2026-10-29 (8-K: https://www.sec.gov/Archives/edgar/data/1996862/000162828026068051/)
- Next earnings: 2027-01-29 (expected; the company has not confirmed it)

| Filed | Form | Headline | Period end | XBRL document | Link |
| --- | --- | --- | --- | --- | --- |
| 2026-11-03 | 8-K | New material agreement and New debt or financial obligation |  | bg-20261030 | https://www.sec.gov/Archives/edgar/data/1996862/000162828026069484/bg-20261030.htm |
| 2026-10-29 | 10-Q | Quarterly report for the period ended Sep 30, 2026 | 2026-09-30 | bg-20260930 | https://www.sec.gov/Archives/edgar/data/1996862/000162828026068130/bg-20260930.htm |
| 2026-10-29 | 8-K | Earnings release |  | bg-20261029 | https://www.sec.gov/Archives/edgar/data/1996862/000162828026068051/ |
| 2026-10-05 | 8-K | Change of directors or officers |  | bg-20261005 | https://www.sec.gov/Archives/edgar/data/1996862/000162828026064933/bg-20261005.htm |
| 2026-09-21 | 8-K | Other company news |  | bg-20260917 | https://www.sec.gov/Archives/edgar/data/1996862/000162828026062880/bg-20260917.htm |
| 2026-09-03 | 8-K | Change of directors or officers |  | bg-20260901 | https://www.sec.gov/Archives/edgar/data/1996862/000162828026060388/bg-20260901.htm |
| 2026-08-19 | 8-K | Other company news |  |  | https://www.sec.gov/Archives/edgar/data/1996862/000110465926098782/tm2623458d1_8k.htm |
| 2026-07-29 | 10-Q | Quarterly report for the period ended Jun 30, 2026 | 2026-06-30 | bg-20260630 | https://www.sec.gov/Archives/edgar/data/1996862/000162828026050540/bg-20260630.htm |
| 2026-07-29 | 8-K | Earnings release |  | bg-20260729 | https://www.sec.gov/Archives/edgar/data/1996862/000162828026050334/ |
| 2026-05-22 | 8-K | Shareholder vote results |  | bg-20260520 | https://www.sec.gov/Archives/edgar/data/1996862/000162828026037544/bg-20260520.htm |

Every filing on SEC EDGAR (CIK 1996862): https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001996862&type=&dateb=&owner=include&count=40

## Risks

- High: Processing margins depend on crops, trade flows, biofuel rules and the wars in Ukraine and the Middle East. A change in US biofuel policy or the end of trade disruption can reduce margins fast.
- Medium: Total debt was $16,746 million at September 30, 2026, up from $14,051 million at December 31, 2025, because Bunge borrowed to fund higher inventories. Bunge expects net interest expense of $640 to $670 million in 2026.
- Medium: The Viterra combination is large and complex. The combination raised the number of registered shares from about 134 million to about 193 million. If Bunge does not get the planned savings, earnings per share can stay low.
- Medium: Bunge has operations in Ukraine and other countries with war, sanctions or currency risk. In Q3 2026, it recorded charges and a tax valuation allowance because of the war in Ukraine.
- Low: Results of Tropical Oils and Specialty Ingredients were lower in 2026 because of trade disruption and start-up costs, and Bunge lowered its 2026 outlook for this segment in October 2026.

## Links

- Page: https://picks.utilarium.app/company/BG/
- History of changes: https://picks.utilarium.app/company/BG/history/
- JSON with full history: https://picks.utilarium.app/data/company/BG.json

> Picks is a personal record of stock picks. It gives general opinions about stocks, including a "Top pick" label. They are not tailored to your needs, goals or risk tolerance. Kevin is not a registered adviser and relies on the general-advice exemption in Canadian securities law (NI 31-103 s.8.25). Do your own research, or ask a registered adviser. Kevin may hold any stock on this site. Prices, intrinsic values and ratings can be delayed or wrong; check the original source. Full disclaimer: /disclaimer/.
